国内丙型肝炎治疗药物的临床应用  

作　　者：田姗[1] 郝竟琳 韩杰[1] 张静姝[1] 陈倩[1] 朱姗薇[1] 

机构地区：[1]解放军第302医院,100039

出　　处：《首都食品与医药》2017年第8期70-72,共3页Capital Food Medicine

摘　　要：丙型肝炎作为一种难治型传染病,其症状较隐匿,漏诊率高,经血传播比例高,而一般公众对其认知程度较低,接受抗病毒治疗的比例更低。本文从丙型肝炎的流行特征及流行趋势入手,结合丙型肝炎的治疗目标,着重介绍了三种丙型肝炎常用治疗药物的疗效特点及联合用药方案,指出丙肝患者抗病毒治疗的重要性及预期效果。引用《中国肝病防治指南》,列举一线治疗方案,对临床用药有一定指导意义。As a kind of intractable infectious disease, hepatitis C has a higher rate of misdiagnosis and a higher proportion of blood transmission. The general public has a lower aware rate of rece therapy. This ness rate and a lower lying antiretroviral paper introduces the characteristics, epidemics tre and treatment goals of hepati C, highlighting the three commo used treatm hepatitis C pr of C ent drug efficacy and combination of ogram, pointing out anti-viral treatmen nds tis nly of the the importance t of hepatitis patients and expectations effect Reference ＂Chinese liver disease prevention guide＂, lists the first- line treatment program, has a certain guiding significance in clinical drug application.

关 键 词：丙型肝炎 治疗药物 临床应用 

分 类 号：R512.63[医药卫生—内科学]